Clinical trial
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal…
NCT00489086 · UCSF Benioff Children's Hospital Oakland, Other · Completed
Key facts
| NCT number | NCT00489086 |
|---|---|
| Title | Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face |
| Official title | A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCC's With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome |
| Lead sponsor | UCSF Benioff Children's Hospital Oakland, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplastic Syndrome |
| Intervention type | Drug |
| Interventions | tazarotene |
| Enrollment | 36 |
| Start date | Jul 1, 2004 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Jun 21, 2007 |
| Last update posted | Oct 29, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: